Home/Filings/4/0000905718-22-000184
4//SEC Filing

Mack Anthony P. 4

Accession 0000905718-22-000184

CIK 0001708331other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:02 PM ET

Size

5.3 KB

Accession

0000905718-22-000184

Insider Transaction Report

Form 4
Period: 2022-01-31
Mack Anthony P.
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-31+150,000150,000 total
    Exercise: $2.34Exp: 2032-01-31Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option vests in three equal annual installments commencing on January 31, 2023.

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1
  • filerCIK 0001818483

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:02 PM ET
Size
5.3 KB